Sequencing Reveals Entire Fetal Genome in Maternal Plasma; Opens Door for Noninvasive Prenatal Tests
December 14, 2010
Sequencing Reveals Entire Fetal Genome in Maternal Plasma; Opens Door for Noninvasive Prenatal Tests
Showing that the entire fetal genome is present in maternal plasma is important because "then one might be able to scan the entire fetal genome for genetic disorders using this noninvasive approach."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Two Sequencing-Based Prenatal Tests Make Strides Toward the Clinic
January 18, 2011 / In Sequence - Lo Team Finds Targeted, SNP-Based Approach for T21 Detection 'Less Robust' than Shotgun Sequencing
May 30, 2012 / Clinical Sequencing News - Quake Group Issued Patent for Detection of Fetal Aneuploidy with Next-Gen Sequencing
August 31, 2011 / Clinical Sequencing News - Building on Trisomy 21 Test, Hong Kong Team Develops Method to Detect T13 and T18
July 6, 2011 / Clinical Sequencing News - Cypriot Group Develops Non-Invasive, Prenatal Down Syndrome Dx; Creates Startup to Market Test
March 10, 2011 / PCR Insider